• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄牙型家族性淀粉样多神经病患者肝移植后心肌病的进展

Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type.

作者信息

Olofsson Bert-Ove, Backman Christer, Karp Kjell, Suhr Ole B

机构信息

Department of Internal Medicine, Umeå University Hospital, SE 901 85 Umeå, Sweden.

出版信息

Transplantation. 2002 Mar 15;73(5):745-51. doi: 10.1097/00007890-200203150-00015.

DOI:10.1097/00007890-200203150-00015
PMID:11907421
Abstract

BACKGROUND

Transthyretin amyloidosis is today an accepted indication for orthotopic liver transplantation (OLT). For several mutations progression of the cardiomyopathy has been observed after OLT. The aim of this study was to assess the course of cardiac involvement in Swedish familial amyloidotic polyneuropathy (FAP), Portuguese type, after OLT. By comparison of the echocardiographic findings before OLT with those obtained after, the course of the heart involvement was followed.

METHODS

Twenty-three patients, who had undergone OLT and were examined with echocardiography 1-12 months before OLT, were available for the study. Twenty-one patients were examined 12-27 months after OLT, and 12 were re-examined 52-71 months after OLT. Two-dimensional and M-mode echocardiography were performed in accordance with the standards of the American Society of Echocardiography.

RESULTS

A significantly increased septal and left ventricular posterior wall thickness and a significantly increased left atrial dimension was observed at the post-OLT examinations, indicating a progression of the amyloid heart disease. This increase of the cardiac involvement was neither correlated to waiting time for OLT or to pre-operative signs of cardiomyopathy.

CONCLUSIONS

Even though the production of the amyloidogenic-mutated transthyretin is stopped by OLT, the cardiomyopathy may progress after the operation even for the Portuguese type of FAP. The increase of the septal and left ventricular posterior wall thickness after OLT is not restricted to patients with signs of left ventricular hypertrophy before the transplantation. The findings have important implications for the follow-up of FAP patients after OLT.

摘要

背景

如今,转甲状腺素蛋白淀粉样变性是原位肝移植(OLT)的一个公认适应证。对于几种突变类型,OLT后已观察到心肌病进展。本研究的目的是评估瑞典型葡萄牙家族性淀粉样多神经病(FAP)患者OLT后心脏受累的病程。通过比较OLT前与OLT后的超声心动图检查结果,追踪心脏受累的病程。

方法

本研究纳入23例接受OLT且在OLT前1至12个月接受超声心动图检查的患者。21例患者在OLT后12至27个月接受检查,12例患者在OLT后52至71个月接受复查。二维和M型超声心动图检查按照美国超声心动图学会的标准进行。

结果

OLT后的检查发现,室间隔和左心室后壁厚度显著增加,左心房内径显著增大,提示淀粉样心脏病进展。心脏受累的这种增加与OLT等待时间或术前心肌病体征均无相关性。

结论

尽管OLT可阻止淀粉样变突变型转甲状腺素蛋白的产生,但即使是葡萄牙型FAP患者,术后心肌病仍可能进展。OLT后室间隔和左心室后壁厚度增加并不局限于移植前有左心室肥厚体征的患者。这些发现对FAP患者OLT后的随访具有重要意义。

相似文献

1
Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type.葡萄牙型家族性淀粉样多神经病患者肝移植后心肌病的进展
Transplantation. 2002 Mar 15;73(5):745-51. doi: 10.1097/00007890-200203150-00015.
2
Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.家族性淀粉样多神经病肝移植十年国际经验:来自家族性淀粉样多神经病世界移植登记处的结果
Transplantation. 2004 Jan 15;77(1):64-71. doi: 10.1097/01.TP.0000092307.98347.CB.
3
Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients.肝移植不能预防葡萄牙型(ATTR Val30Met)家族性淀粉样多神经病患者发生危及生命的心律失常。
Transplantation. 2004 Jul 15;78(1):112-6. doi: 10.1097/01.tp.0000133517.20972.27.
4
[Myocardiopathy caused by Portuguese-type familial amyloidotic polyneuropathy. Sequential morphologic and functional study of 60 patients].[葡萄牙型家族性淀粉样多神经病所致心肌病。60例患者的序贯形态学和功能研究]
Rev Port Cardiol. 1991 Dec;10(12):909-16.
5
Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis.家族性淀粉样多神经病肝移植后进展性心脏淀粉样变性:对淀粉样纤维形成的影响
Transplantation. 1998 Jul 27;66(2):229-33. doi: 10.1097/00007890-199807270-00016.
6
Liver transplantation and transthyretin amyloidosis.肝移植与转甲状腺素蛋白淀粉样变性。
Muscle Nerve. 2013 Feb;47(2):157-62. doi: 10.1002/mus.23521. Epub 2012 Nov 21.
7
Liver transplantation in transthyretin-related familial amyloid polyneuropathy.转甲状腺素蛋白相关家族性淀粉样多神经病的肝移植
Curr Opin Neurol. 2004 Oct;17(5):615-20. doi: 10.1097/00019052-200410000-00012.
8
Combined heart and liver transplantation for familial amyloidotic neuropathy.心脏和肝脏联合移植治疗家族性淀粉样变性神经病。
Eur J Cardiothorac Surg. 2007 Jul;32(1):180-2. doi: 10.1016/j.ejcts.2007.03.023. Epub 2007 Apr 20.
9
Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR) and the Domino Liver Transplant Registry (DLTR).家族性淀粉样多神经病世界移植登记处(FAPWTR)和多米诺肝移植登记处(DLTR)的报告。
Amyloid. 2003 Aug;10 Suppl 1:67-76.
10
Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.转甲状腺素蛋白丙氨酸 60 变异相关家族性淀粉样多发性神经病的心脏表型和临床转归。
Eur Heart J. 2012 May;33(9):1120-7. doi: 10.1093/eurheartj/ehr383. Epub 2011 Oct 11.

引用本文的文献

1
Inhibitors of Transthyretin Amyloidosis: How to Rank Drug Candidates Using X-ray Crystallography Data.转甲状腺素蛋白淀粉样变性抑制剂:如何利用 X 射线晶体学数据对候选药物进行排序。
Molecules. 2024 Feb 18;29(4):895. doi: 10.3390/molecules29040895.
2
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation.肝移植后遗传性转甲状腺素蛋白介导的淀粉样变性多发性神经病患者的帕替沙尼治疗。
Am J Transplant. 2022 Jun;22(6):1646-1657. doi: 10.1111/ajt.17009. Epub 2022 Mar 26.
3
A Novel Case of Idiopathic Restrictive Cardiomyopathy.
特发性限制性心肌病一例新病例
Cureus. 2020 Mar 8;12(3):e7212. doi: 10.7759/cureus.7212.
4
Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.转甲状腺素蛋白心脏淀粉样变:诊断与治疗的最新进展。
ESC Heart Fail. 2019 Dec;6(6):1128-1139. doi: 10.1002/ehf2.12518. Epub 2019 Sep 25.
5
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.美国核医学与分子影像学会/美国心脏协会/美国超声心动图学会/欧洲核医学协会/美国心力衰竭学会/美国心律学会/心血管磁共振学会/美国核医学与分子影像学会关于心脏淀粉样变性多模态成像的专家共识建议:第1部分——证据基础和标准化成像方法
J Nucl Cardiol. 2019 Dec;26(6):2065-2123. doi: 10.1007/s12350-019-01760-6.
6
New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center's experience.遗传性转甲状腺素蛋白淀粉样变性患者临床评估的新见解:单中心经验
Degener Neurol Neuromuscul Dis. 2012 Aug 28;2:93-106. doi: 10.2147/DNND.S24652. eCollection 2012.
7
Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis?核医学成像技术能否预测遗传性转甲状腺素蛋白心脏淀粉样变患者的预后并指导医学管理?
Curr Cardiol Rep. 2018 Mar 24;20(5):33. doi: 10.1007/s11886-018-0976-9.
8
An Isolated Case of Late-onset Amyloidogenic Transthyretin Type Familial Amyloid Polyneuropathy Associated with a Mutant Transthyretin Substituting Methionine for Valine at Position 30 Showing Latent Progressive Cardiac Involvement Confirmed by Serial Annual Electrocardiograms.一例迟发性甲状腺素运载蛋白型家族性淀粉样多神经病孤立病例,与在第30位缬氨酸被甲硫氨酸替代的突变型甲状腺素运载蛋白相关,经连续年度心电图证实存在潜在进行性心脏受累。
Intern Med. 2017;56(2):163-168. doi: 10.2169/internalmedicine.56.7562. Epub 2017 Jan 15.
9
Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells.在患者来源的类肝细胞中评估治疗性寡核苷酸对家族性淀粉样多神经病的疗效
PLoS One. 2016 Sep 1;11(9):e0161455. doi: 10.1371/journal.pone.0161455. eCollection 2016.
10
Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?转甲状腺素蛋白淀粉样变性神经病比原发性淀粉样变性病有更早的神经受累,但预后更好:这是对这一矛盾现象的解答吗?
Ann Neurol. 2016 Sep;80(3):401-11. doi: 10.1002/ana.24725. Epub 2016 Jul 25.